Evidence map›Paper›PMID 32343490›Full record

ArticleCurrent protocols in bioinformatics2020

QIIME 2 Enables Comprehensive End-to-End Analysis of Diverse Microbiome Data and Comparative Studies with Publicly Available Data.

Mehrbod Estaki, Lingjing Jiang, Nicholas A Bokulich, Daniel McDonald, Antonio González, Tomasz Kosciolek, Cameron Martino, Qiyun Zhu, Amanda Birmingham, Yoshiki Vázquez-Baeza and 4 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Current protocols in bioinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 279 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
279citing papers in PubMed, 2 pooled it
18.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

279 citing papers in PubMed, 2 syntheses or guidelines pooled it, 536 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. DietaryAnimals : an open access journal from MDPI · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  14. PasteurizedMicrobiology spectrum · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. A Novel Blend ofFoods (Basel, Switzerland) · 2026
    Article
  19. Article
  20. Article

219 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Mehrbod EstakiDepartment of Pediatrics, University of California San Diego, La Jolla, California.
Lingjing JiangDivision of Biostatistics, University of California San Diego, La Jolla, California.
Nicholas A BokulichCenter for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona.
Daniel McDonaldDepartment of Pediatrics, University of California San Diego, La Jolla, California.
Antonio GonzálezDepartment of Pediatrics, University of California San Diego, La Jolla, California.
Tomasz KosciolekDepartment of Pediatrics, University of California San Diego, La Jolla, California.
Cameron MartinoBioinformatics and Systems Biology Program, University of California San Diego, La Jolla, California.
Qiyun ZhuDepartment of Pediatrics, University of California San Diego, La Jolla, California.
Amanda BirminghamCenter for Computational Biology and Bioinformatics, University of California San Diego, La Jolla, California.
Yoshiki Vázquez-BaezaCenter for Microbiome Innovation, University of California San Diego, La Jolla, California.
Matthew R DillonCenter for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona.
Evan BolyenCenter for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona.
J Gregory CaporasoCenter for Applied Microbiome Science, Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona.
Rob KnightDepartment of Pediatrics, University of California San Diego, La Jolla, California.
University of California, San Diego · USNorthern Arizona University · USUniversity of California System · US

Funding

UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
NCATS NIH HHS UL1 TR001442
6 · The paper itself

Abstract

QIIME 2 is a completely re-engineered microbiome bioinformatics platform based on the popular QIIME platform, which it has replaced. QIIME 2 facilitates comprehensive and fully reproducible microbiome data science, improving accessibility to diverse users by adding multiple user interfaces. QIIME 2 can be combined with Qiita, an open-source web-based platform, to re-use available data for meta-analysis. The following basic protocol describes how to install QIIME 2 on a single computer and analyze microbiome sequence data, from processing of raw DNA sequence reads through generating publishable interactive figures. These interactive figures allow readers of a study to interact with data with the same ease as its authors, advancing microbiome science transparency and reproducibility. We also show how plug-ins developed by the community to add analysis capabilities can be installed and used with QIIME 2, enhancing various aspects of microbiome analyses-e.g., improving taxonomic classification accuracy. Finally, we illustrate how users can perform meta-analyses combining different datasets using readily available public data through Qiita. In this tutorial, we analyze a subset of the Early Childhood Antibiotics and the Microbiome (ECAM) study, which tracked the microbiome composition and development of 43 infants in the United States from birth to 2 years of age, identifying microbiome associations with antibiotic exposure, delivery mode, and diet. For more information about QIIME 2, see https://qiime2.org. To troubleshoot or ask questions about QIIME 2 and microbiome analysis, join the active community at https://forum.qiime2.org. © 2020 The Authors. Basic Protocol: Using QIIME 2 with microbiome data Support Protocol: Further microbiome analyses.

Indexed as

Databases as TopicMicrobiotaSoftwareBiodiversityLinear ModelsPhylogenybioinformaticsmetagenomicsmicrobiomeQIIME 2Qiita

Identifiers

PMID32343490
PMCPMC9285460
OpenAlexW3019168548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.